LANXESS AG

LANXESS AG

2.81
USD
-0.03
(-1.06%)
-1.73EPS
1.21BMarket Cap
Mar 17Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
19.9
18.05
17.23
16.78
14.23
14.88
15.36
14.06
14.1
18.69
15.51
14.71
13.11
13.11
Basic EPS, GAAP
-0.38
0.11
0.36
0.42
0.19
0.94
0.46
2.04
0.62
0.58
1.02
-0.41
-1.33
-1.53
Free Cash Flow per Basic Share
-1.46
-0.97
-0.38
-0.41
1.03
0.23
0.3
0.3
-0.04
-0.57
1.18
0.43
-0.07
0.32
Dividend per Share
0.2
0.1
0.1
0.12
0.14
0.16
0.18
0.19
0.2
0.21
0.21
0.02
0.02
0.02
Book Value per Share
4.54
4.71
5.04
5.56
4.99
6.06
6.09
6.93
8.68
10.21
10.4
10.6
8.08
8.03
Tangible Book Value per Share
3.77
4.01
4.38
4.49
1.1
2.21
2.06
3.13
2.82
2.52
4.11
4.75
3.2
3.22
Basic Weighted Avg Shares
417
443
459
459
459
459
443
434
433
433
433
433
433
433
Sales/Revenue/Turnover
8,300
8,006
7,902
7,699
6,530
6,824
6,802
6,104
6,101
8,088
6,714
6,366
5,673
5,674
Operating Margin (%)
3.46
5.08
7.15
7.31
8.73
8.54
8.57
6.77
5.95
5.27
-0.74
0.79
-0.56
-0.18
Depreciation Expense
717
426
418
481
410
415
503
504
457
546
996
566
806
697
Net Income, GAAP
-159
47
165
192
87
431
205
885
267
250
443
-177
-577
-662
Effective Tax Rate (%)
- -
45
42.01
42.48
72.6
25.98
30.35
15.36
28.83
28.02
- -
- -
- -
- -
Profit Margin (%)
-1.92
0.59
2.09
2.49
1.33
6.32
3.01
14.5
4.38
3.09
6.6
-2.78
-10.17
-11.67
Working Capital
1,337
1,507
1,079
3,725
1,499
2,382
2,148
2,235
2,010
2,424
1,735
1,676
1,046
1,022
LT Debt
1,649
1,698
1,258
2,734
2,242
2,686
2,773
2,262
2,826
3,415
2,937
2,427
1,904
- -
Total Equity
1,900
2,161
2,323
3,728
3,413
2,773
2,647
2,999
3,762
4,427
4,507
4,592
3,500
3,481
Return on Invested Capital (%)
- -
2.86
5.81
4.96
1.25
6.03
5.05
3.73
2.27
2.51
- -
- -
- -
- -
Return on Capital (%)
- -
2.74
5.75
4.82
1.29
7.1
5.33
16.72
4.95
3.94
- -
- -
- -
- -
Return on Common Equity (%)
-7.56
2.32
7.38
7.9
3.6
17.01
7.52
31.22
7.9
6.11
9.93
-3.9
-14.28
-17.95

Capital Structure

EUR

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
433
433
433
Market Capitalization
1,612
1,435
1,072

Working Capital

EUR

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
2,676
3,319
3,262
Cash, Cash Equivalents & STI
569
1,074
1,100
Accounts Receivable, Net
623
708
612
Inventories
1,283
1,329
1,348
Total Current Liabilities
1,592
1,841
2,240
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.51%
4.61%
-23.78%
Free Cash Flow
36.56%
151.99%
-115.96%
Net Income, GAAP
72.34%
17.41%
225.99%
Sales/Revenue/Turnover
-2.44%
-0.11%
-10.89%
Total Cash Common Dividend
- -
- -
11.11%

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,607
1,678
1,598
1,483
6,366
2025
1,601
1,466
1,338
1,268
5,673
2026
1,378
1,561
1,467
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.23
-0.04
- -
-0.15
-0.41
2025
-0.13
-0.1
-0.18
-0.92
-1.33
2026
-0.33
-0.12
-0.16
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.02
- -
- -
0.02
2025
- -
0.02
- -
- -
0.02
2026
- -
0.02
- -
- -
- -

Company Description

CEO
Matthias Zachert
Full Time Employees
11,709
Sector
Process industries
Industry
Chemicals: major diversified
Address
Kennedyplatz 1 Cologne NW Germany 50569
IPO Date
Nov 2, 2007
Business
Lanxess AG (LXS.DE) is a leading specialty chemicals company that develops, manufactures and markets advanced chemical intermediates, additives, and consumer protection products worldwide. The company operates through four main segments: Specialty Additives, which includes flame retardants, plastic additives and lubricants under brands such as Baymod, Durethan and TeFax; Consumer Protection, offering microbial control solutions, odor control and functional hygiene products like Preventol and KATHON; Engineering Materials, providing high-performance plastics and elastomers such as Durethan polyamides, Pocan polyesters and Crastin; and Arlanxeo, its rubber business joint venture with Saudi Aramco producing synthetic rubbers including Buna. Lanxess serves industries including automotive, construction, agriculture, electronics, energy, and personal care, with manufacturing sites and sales offices across more than 60 countries in Europe, Asia, North and South America, and the Middle East. Founded in 2004 as a spin-off from Bayer AG and headquartered in Cologne, Germany, the company continues to focus on sustainable innovation and circular economy solutions. In recent developments, Lanxess completed the acquisition of a majority stake in the biobased chelator business from Ataman Kimya in 2024, expanding its sustainable metal decontamination offerings for detergents and cleaners; it also formed a strategic partnership with Trinseo in 2024 to develop sustainable flame-retardant polymer compounds using recycled materials. The company divested its leather chemicals business to TFL in 2023 and its chrome chemicals effects business to a consortium led by 3CR Partners in 2024, streamlining its portfolio toward higher-growth specialty segments. Additionally, Lanxess launched new product lines including ion exchange resins for water treatment and advanced anti-corrosion coatings in 2025, alongside expanding production capacity for engineering plastics in China and the U.S. to meet rising demand in electric vehicles and renewable energy applications. These moves reflect Lanxess' ongoing strategic shift toward sustainability-driven growth and operational efficiency.

Company News

  • LANXESS Aktiengesellschaft (LNXSY) Q3 2026 Press Conference Call Transcript

  • LANXESS Aktiengesellschaft (LNXSY) Q3 2026 Earnings Call Transcript

  • What LANXESS Aktiengesellschaft (LXS) Said on Its Q3 Earnings Call

  • Oakmark International Small Cap Strategy Q2 2026 Contributors And Detractors

  • LANXESS Aktiengesellschaft (LNXSY) Q2 2026 Earnings Call Transcript

  • LANXESS Aktiengesellschaft (LNXSY) Q2 2026 Press Conference Call Transcript

  • LANXESS Aktiengesellschaft Q2 Earnings Call Highlights

  • LANXESS Aktiengesellschaft (LNXSY) Shareholder/Analyst Call Prepared Remarks Transcript

  • LANXESS Aktiengesellschaft (LNXSY) Q1 2026 Earnings Call Transcript

  • LANXESS Aktiengesellschaft (LNXSY) Q1 2026 Press Conference Call Transcript

  • LANXESS Aktiengesellschaft (LNXSY) Q4 2025 Press Conference Call Transcript

  • LANXESS Aktiengesellschaft (LNXSY) Q4 2025 Earnings Call Transcript

  • Oakmark International Small Cap Strategy Q3 2025 Top Contributors And Detractors

  • Lanxess' Q3: Down But Not Out

  • LANXESS Aktiengesellschaft (LNXSY) Q3 2025 Earnings Call Transcript

  • LANXESS Aktiengesellschaft (LNXSY) Q3 2025 Press Conference Call Transcript

  • Lanxess: The Best Anticyclical Bet You Can Make Right Now

  • Lanxess' Unsurprising Envalior Surprise Sale

  • LANXESS Aktiengesellschaft - Special Call

  • Lanxess Is Worth Another Look